S.A. Mason’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.28M | Sell |
12,287
-2
| -0% | -$371 | 1.1% | 16 |
|
|
2025
Q1 | $2.57M | Sell |
12,289
-456
| -4% | -$95.5K | 1.36% | 13 |
|
|
2024
Q4 | $2.26M | Buy |
12,745
+104
| +0.8% | +$18.5K | 1.19% | 14 |
|
|
2024
Q3 | $2.5M | Buy |
12,641
+18
| +0.1% | +$3.56K | 1.32% | 13 |
|
|
2024
Q2 | $2.17M | Buy |
12,623
+336
| +3% | +$57.6K | 1.23% | 14 |
|
|
2024
Q1 | $2.24M | Buy |
12,287
+20
| +0.2% | +$3.64K | 1.35% | 13 |
|
|
2023
Q4 | $1.9M | Sell |
12,267
-83
| -0.7% | -$12.9K | 1.27% | 13 |
|
|
2023
Q3 | $1.84M | Sell |
12,350
-548
| -4% | -$81.7K | 1.33% | 14 |
|
|
2023
Q2 | $2.06M | Hold |
12,898
| – | – | 1.49% | 12 |
|
|
2023
Q1 | $2.06M | Buy |
12,898
+214
| +2% | +$34.1K | 1.49% | 12 |
|
|
2022
Q4 | $2.05M | Sell |
12,684
-36
| -0.3% | -$5.82K | 1.54% | 11 |
|
|
2022
Q3 | $1.71M | Sell |
12,720
-171
| -1% | -$22.9K | 1.35% | 11 |
|
|
2022
Q2 | $1.97M | Buy |
12,891
+45
| +0.4% | +$6.89K | 1.44% | 11 |
|
|
2022
Q1 | $2.08M | Buy |
12,846
+556
| +5% | +$90.2K | 1.3% | 12 |
|
|
2021
Q4 | $1.66M | Buy |
12,290
+16
| +0.1% | +$2.17K | 1% | 19 |
|
|
2021
Q3 | $1.32M | Buy |
12,274
+738
| +6% | +$79.6K | 0.87% | 25 |
|
|
2021
Q2 | $1.3M | Sell |
11,536
-2
| -0% | -$225 | 0.89% | 27 |
|
|
2021
Q1 | $1.25M | Sell |
11,538
-16
| -0.1% | -$1.73K | 0.93% | 24 |
|
|
2020
Q4 | $1.24M | Sell |
11,554
-92
| -0.8% | -$9.86K | 1.03% | 20 |
|
|
2020
Q3 | $1.02M | Buy |
11,646
+8
| +0.1% | +$701 | 0.97% | 29 |
|
|
2020
Q2 | $1.14M | Buy |
11,638
+8
| +0.1% | +$786 | 1.2% | 15 |
|
|
2020
Q1 | $886K | Sell |
11,630
-66
| -0.6% | -$5.03K | 1.08% | 20 |
|
|
2019
Q4 | $1.04M | Buy |
+11,696
| New | +$1.04M | 0.99% | 24 |
|